CURRENT HEADLINES
- Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted To Nexiguran Ziclumeran (nex-z) For The Treatment Of Hereditary Transthyretin (ATTR) Amyloidosis With Polyneuropathy
- Eton Pharmaceuticals Announces Acquisition Of U.S. Rights To Amglidia (Glyburide Oral Suspension)
- Duality Biologics Announces Expansion Of Adcendo ApS Collaboration Through Option Exercise Of Strategic License Agreement
- GC Biopharma And Novel Pharma First Patient Dosed In Global Phase I Clinical Trial For MPS IIIA Treatment
- Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology For Drug Development
SUPPLIER NEWS
- New 50 Microliter Electronic Pipettes
- Powerful Evaporator For Drug Discovery
- Capsugel Expands Global Manufacturing For Finished Dosage Forms
- CAMO Releases New Version Of The Unscrambler® X Multivariate Data Analysis And Design Of Experiments Software
- Leading Vaccine Manufacturer Boosts IT Efficiency And Reduces TCO By 20%
ARCHIVE NEWSLETTER
- 12.03.24 -- How To Overcome Immune Rejection In iPSC-based Gene Therapy
- 12.02.24 -- Streamline Your Oral Drug Development Process
- 11.27.24 -- Find The Perfect CDMO Partner For Your Project
- 11.26.24 -- Emerging Partnership Trends In Oligo-Based Medicines
- 11.25.24 -- Choosing The Ideal CDMO Partner For Your Project
BUSINESS WIRE PRESS
- Alnylam Announces U.S. Food And Drug Administration Acceptance Of Supplemental New Drug Application For Vutrisiran For The Treatment Of ATTR Amyloidosis With Cardiomyopathy
- Amneal Resubmits DHE Autoinjector New Drug Application And Receives U.S. FDA Approval Of Exenatide, Its First Generic Injectable GLP-1 Agonist
- Laekna Announces A Clinical Collaboration With Lilly To Develop LAE102, A Novel Monoclonal Antibody Targeting Activin Receptor Type 2A For The Treatment Of Obesity
- GeneDx Fuels Rare Disease Drug Discovery With Launch Of GeneDx Discover
- Sangamo Therapeutics Announces U.S. FDA Clearance Of IND Application For ST-503 For The Treatment Of Idiopathic Small Fiber Neuropathy, A Type Of Chronic Neuropathic Pain
- Arrowhead Pharmaceuticals Submits New Drug Application To U.S. FDA For Plozasiran For The Treatment Of Familial Chylomicronemia Syndrome
DOWNLOAD LIBRARY
Download FREE software, tools, and resources. Our download library is packed with the latest industry releases. Add your demos to the list for FREE.
| • | Download software |
EVENTS CALENDAR
Learn about upcoming industry events. Our events calendar will help you stay current with industry meetings, upcoming conferences, and more. You can also post your industry event and generate highly qualified interest.
| • | Search events |
| • | Post events |
| • | Stay informed |
Learn more...
ASSOCIATIONS
Looking for an industry association? Search our listings to find the association that fits your specialty.
Browse now...This website uses cookies to ensure you get the best experience on our website. Learn more